RESET (Retatrutide) is a triple GLP-1/GIP/glucagon receptor agonist — one of the most studied metabolic compounds currently in research. CUT (Tesamorelin) is the most clinically validated compound in this lineup, with Phase III data on visceral adipose reduction via pulsatile GH stimulation. Different mechanisms, converging on body composition research.

All IRIX products are intended solely for laboratory research purposes and are not for human or animal consumption. These materials are not intended to diagnose, treat, cure, or prevent any disease. For research use only.